Evolent Health
EVH
Evolent Health (EVH) news
Recent news
Evolent Health raises 2026 revenue guidance to $2.6-$2.70 bln
AInvest Wire · Aug 6, 2026Evolent Health expects 2027 revenue growth over 25% compared to 2026 and adj EBITDA midpoint at or above $150 mln
AInvest Wire · Aug 6, 2026EVH sees FY revenue $2.6B to $2.7B, saw $2.4B to $2.6B, est. $2.5B
Evolent Health (NYSE: EVH) has provided updated revenue guidance for the fiscal year, projecting total revenue in the range of $2.6 billion to $2.7 billion. This represents an increase from the previous estimate of $2.4 billion to $2.6 billion, with new range midpoint at $2.65 billion compared to…
AInvest Wire · Aug 6, 2026Evolent 2Q adj. EBITDA $28.1M, est. $22.7M
AInvest Wire · Aug 6, 2026Evolent 2Q revenue $652.5M, estimate $598.1M
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.